For the first time since the pandemic started, we are pleased to announce that the 9th Annual HealthTech Investment Forum (HTIF) will take place on the 20th of September 2022 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week, which will also incorporate the 22nd Annual Biotech in Europe Forum. The physical programme will consist of the usual panels and keynotes, which will be available on demand the week after. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. The in-person event will be followed by an additional week of virtual meetings available through the audio/video online meeting system. 

The main programme for the 9th Annual HTIF will feature more than 7 hours of high-level speeches and panel discussions. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presenting tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 300+ delegates drawn from Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

Read on sachsforum.com

Continue reading at sachsforum.com

Health Technology Investments

Facebook Share

Twitter Share

Linkedin Share

Email Share